The aim of this study was to find a suitable biomarker for pyrethroid adver
se effects. It was shown that there is a correlation between the half-life
time (t(1/2)) of pyrethroids in plasma and the clinical findings. We hypoth
ized that this finding indicates an interindividual different amount of tot
al esterase activity or even a polymorphism. By in vitro experiments it was
demonstrated that pyrethroids are cleaved by carboxylesterases. After it t
urned out that carboxylesterase activity in human plasma is too low for det
ection, a method for specific determination of carboxylesterase activity in
human isolated lymphocytes was developed. As a substrate for carboxylester
ase activity, cyfluthrin was added to the lymphocyte suspension. As a proof
for cyfluthrin degradation by carboxylesterases the produced hydrocyanic a
cid was determined by GC/MS. First hints for interindividual differences in
carboxylesterase activity in lymphocytes were found. (C) 1999 Elsevier Sci
ence Ireland Ltd. All rights reserved.